Eliksa Therapeutics launched with University of Utah’s commercial and clinical-stage regenerative medicine technology
University of UtahEliksa Therapeutics, a regenerative medicine company developing novel therapeutics for a range of debilitating diseases, announced today it has launched with investments from the University of Utah (U) and Militia Hill Ventures (MHV) to develop and commercialize multiple clinical programs using the regenerative medicine technology developed at the U.